dreddymd Cancer, Dangerous Drugs and Medicine, Diseases & Disorders, News & Reviews

Diabetes and obesity drugs linked to thyroid cancer

The European Medicines Agency (EMA), the European Union's (EU) version of the Food and Drug Administration (FDA), issued a drug safety signal this week about the elevated thyroid cancer risk associated with certain classes of pharmaceuticals for Type 2 diabetes and obesity. Semaglutide, the active ingredient found in the widely used anti-diabetes and anti-obesity drugs Ozempic and … Continue reading Diabetes and obesity drugs linked to thyroid cancer